Anritsu Pharmaceutical X-ray Inspection System can identify transdermal patches caught in sealed areas and broken or missing pieces of orally-disintegrating tablets that were previously undetectable.
The Anritsu Pharmaceutical X-ray Inspection System is equipped with a new X-ray unit most suitable for the inspection of thin products, which easily transmit x-rays. With significantly improved X-ray image quality and reduced variation in quality, which occurs in visual and tactile inspections, the system contributes to quality stabilisation.
Our unique technology minimises x-ray leakage so that a product with a height of 10mm or less can be conveyed without touching the leakage prevention curtain, which reduces the problem with false rejects caused by product jam or the disturbance of product orientation during conveyance. It also ensures that defective products are properly rejected at the correct timing.
The Anritsu Pharmaceutical X-ray Inspection System provides not only contaminant detection but also product verification simultaneously. Products in various types of retail packaging can be inspected for shape, count, and package check.
The KXE7510DGEKE model corresponds FDA 21 CFR Part 11 regulation with Eligibility authentication, Audit trail, Data encryption and decryption which all deliver a piece of mind to processors in the pharmaceutical industries.
- Eligibility authentication (User management)
- Audit trail
- Data encryption and decryption